BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 50624231 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(Cc3ccc(Cl)cc3Cl)CC2)c(Cl)c1 |r| InChI=1S/C24H30Cl3N5O/c1-16-14-31(23-22(27)11-18(13-29-23)24(33)28-2)9-10-32(16)20-5-7-30(8-6-20)15-17-3-4-19(25)12-21(17)26/h3-4,11-13,16,20H,5-10,14-15H2,1-2H3,(H,28,33) FYCDEDPNQQTXCA-UHFFFAOYSA-N 50337210 (S)-5-chloro-6-(4-(1-(2,4-dichlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-methylnicotinamide::CHEMBL1681833 C-X-C chemokine receptor type 3 Homo sapiens 17 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337210 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337210&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53318510 125087312 CHEMBL1681833 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624232 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(Cc3ccc(F)cc3Cl)CC2)c(Cl)c1 |r| InChI=1S/C24H30Cl2FN5O/c1-16-14-31(23-22(26)11-18(13-29-23)24(33)28-2)9-10-32(16)20-5-7-30(8-6-20)15-17-3-4-19(27)12-21(17)25/h3-4,11-13,16,20H,5-10,14-15H2,1-2H3,(H,28,33) KOZSBJWFYXGPEC-UHFFFAOYSA-N 50337211 (S)-5-chloro-6-(4-(1-(2-chloro-4-fluorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-methylnicotinamide::CHEMBL1681843 C-X-C chemokine receptor type 3 Homo sapiens 58 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337211 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337211&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53318513 125087313 CHEMBL1681843 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624233 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(CC2)C(C)c2ccc(Cl)cc2)c(Cl)c1 |r| InChI=1S/C25H33Cl2N5O/c1-17-16-31(24-23(27)14-20(15-29-24)25(33)28-3)12-13-32(17)22-8-10-30(11-9-22)18(2)19-4-6-21(26)7-5-19/h4-7,14-15,17-18,22H,8-13,16H2,1-3H3,(H,28,33) FJEIYFQAVBQPFG-UHFFFAOYSA-N 50337212 5-chloro-6-((3S)-4-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-methylnicotinamide::CHEMBL1681832 C-X-C chemokine receptor type 3 Homo sapiens 5 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337212 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337212&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53322459 125087314 CHEMBL1681832 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624234 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(CC2)C(C)c2ccc(Cl)cc2)c(Cl)c1 |r| InChI=1S/C25H33Cl2N5O/c1-17-16-31(24-23(27)14-20(15-29-24)25(33)28-3)12-13-32(17)22-8-10-30(11-9-22)18(2)19-4-6-21(26)7-5-19/h4-7,14-15,17-18,22H,8-13,16H2,1-3H3,(H,28,33) FJEIYFQAVBQPFG-UHFFFAOYSA-N 50337212 5-chloro-6-((3S)-4-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-methylnicotinamide::CHEMBL1681832 C-X-C chemokine receptor type 3 Homo sapiens 5.00 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337212 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337212&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53322459 125087314 CHEMBL1681832 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624235 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(CC2)C2CCc3cc(Cl)ccc23)c(Cl)c1 |r| InChI=1S/C26H33Cl2N5O/c1-17-16-32(25-23(28)14-19(15-30-25)26(34)29-2)11-12-33(17)21-7-9-31(10-8-21)24-6-3-18-13-20(27)4-5-22(18)24/h4-5,13-15,17,21,24H,3,6-12,16H2,1-2H3,(H,29,34) OGWJKZBNEAPGLN-UHFFFAOYSA-N 50337213 5-chloro-6-((3S)-4-(1-(5-chloro-2,3-dihydro-1H-inden-1-yl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-methylnicotinamide::CHEMBL1681844 C-X-C chemokine receptor type 3 Homo sapiens 29 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337213&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53326850 125087315 CHEMBL1681844 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624236 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(CC2)C2CCc3cc(Cl)ccc23)c(Cl)c1 |r| InChI=1S/C26H33Cl2N5O/c1-17-16-32(25-23(28)14-19(15-30-25)26(34)29-2)11-12-33(17)21-7-9-31(10-8-21)24-6-3-18-13-20(27)4-5-22(18)24/h4-5,13-15,17,21,24H,3,6-12,16H2,1-2H3,(H,29,34) OGWJKZBNEAPGLN-UHFFFAOYSA-N 50337213 5-chloro-6-((3S)-4-(1-(5-chloro-2,3-dihydro-1H-inden-1-yl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-methylnicotinamide::CHEMBL1681844 C-X-C chemokine receptor type 3 Homo sapiens 29.0 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337213&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53326850 125087315 CHEMBL1681844 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624237 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(CC2)C(=O)c2ccc(Cl)cc2)c(Cl)c1 |r| InChI=1S/C24H29Cl2N5O2/c1-16-15-30(22-21(26)13-18(14-28-22)23(32)27-2)11-12-31(16)20-7-9-29(10-8-20)24(33)17-3-5-19(25)6-4-17/h3-6,13-14,16,20H,7-12,15H2,1-2H3,(H,27,32) LOEOKZJATRUCAR-UHFFFAOYSA-N 50337214 (S)-5-chloro-6-(4-(1-(4-chlorobenzoyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-methylnicotinamide::CHEMBL1681845 C-X-C chemokine receptor type 3 Homo sapiens 210 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337214&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53318514 125087316 CHEMBL1681845 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624238 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(CC(=O)c3ccc(F)cc3)CC2)c(Cl)c1 |r| InChI=1S/C25H31ClFN5O2/c1-17-15-31(24-22(26)13-19(14-29-24)25(34)28-2)11-12-32(17)21-7-9-30(10-8-21)16-23(33)18-3-5-20(27)6-4-18/h3-6,13-14,17,21H,7-12,15-16H2,1-2H3,(H,28,34) IUGWBZWQMMIWLW-UHFFFAOYSA-N 50337215 (S)-5-chloro-6-(4-(1-(2-(4-fluorophenyl)-2-oxoethyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-methylnicotinamide::CHEMBL1681846 C-X-C chemokine receptor type 3 Homo sapiens >10000 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337215&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53321134 125087317 CHEMBL1681846 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624239 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(CC2)C(=O)c2ccnc3cc(Cl)ccc23)c(Cl)c1 |r| InChI=1S/C27H30Cl2N6O2/c1-17-16-34(25-23(29)13-18(15-32-25)26(36)30-2)11-12-35(17)20-6-9-33(10-7-20)27(37)22-5-8-31-24-14-19(28)3-4-21(22)24/h3-5,8,13-15,17,20H,6-7,9-12,16H2,1-2H3,(H,30,36) HZCDSXBJXLUGNS-UHFFFAOYSA-N 50337216 (S)-5-chloro-6-(4-(1-(7-chloroquinoline-4-carbonyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-methylnicotinamide::CHEMBL1681847 C-X-C chemokine receptor type 3 Homo sapiens >10000 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337216 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337216&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53322503 125087318 CHEMBL1681847 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624240 Fc1ccc(CNC(=O)c2cnc(N3CCN(CC3)C3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)c2)cc1F InChI=1S/C29H31Cl2F2N5O/c30-23-4-1-20(2-5-23)19-36-9-7-24(8-10-36)37-11-13-38(14-12-37)28-25(31)16-22(18-34-28)29(39)35-17-21-3-6-26(32)27(33)15-21/h1-6,15-16,18,24H,7-14,17,19H2,(H,35,39) FMYKWJDOTAPBPQ-UHFFFAOYSA-N 50337217 5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)piperazin-1-yl)-N-(3,4-difluorobenzyl)nicotinamide::CHEMBL1681848 C-X-C chemokine receptor type 3 Homo sapiens 40 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337217&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53322504 125087319 CHEMBL1681848 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624241 C[C@H]1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(cc1Cl)C(=O)NCc1ccc(F)c(F)c1 |r| InChI=1S/C30H33Cl2F2N5O/c1-20-18-38(12-13-39(20)25-8-10-37(11-9-25)19-21-2-5-24(31)6-3-21)29-26(32)15-23(17-35-29)30(40)36-16-22-4-7-27(33)28(34)14-22/h2-7,14-15,17,20,25H,8-13,16,18-19H2,1H3,(H,36,40) KXOXGMSSGWQNPP-UHFFFAOYSA-N 50337218 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-(3,4-difluorobenzyl)nicotinamide::CHEMBL1681849 C-X-C chemokine receptor type 3 Homo sapiens 6 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337218&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53318560 125087320 CHEMBL1681849 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624242 CNC(=O)c1cnc(N2CCN(CC2)C2CCN(Cc3ccc(Cl)cc3)CC2)c(Cl)c1 InChI=1S/C23H29Cl2N5O/c1-26-23(31)18-14-21(25)22(27-15-18)30-12-10-29(11-13-30)20-6-8-28(9-7-20)16-17-2-4-19(24)5-3-17/h2-5,14-15,20H,6-13,16H2,1H3,(H,26,31) NPUSBVULRVXZBZ-UHFFFAOYSA-N 50301346 5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)piperazin-1-yl)-N-methylnicotinamide::CHEMBL565761 C-X-C chemokine receptor type 3 Homo sapiens 560 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50301346 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50301346&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 45484656 104155707 CHEMBL565761 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624243 Clc1ccc(CN2CCC(CC2)N2CCN(CC2)c2ncc(cc2Cl)C(=O)NCc2ccc(Cl)c(Cl)c2)cc1 InChI=1S/C29H31Cl4N5O/c30-23-4-1-20(2-5-23)19-36-9-7-24(8-10-36)37-11-13-38(14-12-37)28-27(33)16-22(18-34-28)29(39)35-17-21-3-6-25(31)26(32)15-21/h1-6,15-16,18,24H,7-14,17,19H2,(H,35,39) UYHRAVUARCMIMP-UHFFFAOYSA-N 50301351 5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)piperazin-1-yl)-N-(3,4-dichlorobenzyl)nicotinamide::CHEMBL578779 C-X-C chemokine receptor type 3 Homo sapiens 35 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50301351 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50301351&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 11599725 104155712 CHEMBL578779 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624244 C[C@H]1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(cc1Cl)C(=O)NCc1ccc(Cl)c(Cl)c1 |r| InChI=1S/C30H33Cl4N5O/c1-20-18-38(12-13-39(20)25-8-10-37(11-9-25)19-21-2-5-24(31)6-3-21)29-28(34)15-23(17-35-29)30(40)36-16-22-4-7-26(32)27(33)14-22/h2-7,14-15,17,20,25H,8-13,16,18-19H2,1H3,(H,36,40) LENKUUPXOOPDDB-UHFFFAOYSA-N 50337219 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-(3,4-dichlorobenzyl)nicotinamide::CHEMBL1681850 C-X-C chemokine receptor type 3 Homo sapiens 16 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337219 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337219&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 45101497 125087321 CHEMBL1681850 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624245 C[C@H]1CN(CCN1c1ncc(cc1Cl)C(=O)NCc1ccc(Cl)c(Cl)c1)C1CCN(Cc2ccc(Cl)cc2)CC1 |r| InChI=1S/C30H33Cl4N5O/c1-20-18-38(25-8-10-37(11-9-25)19-21-2-5-24(31)6-3-21)12-13-39(20)29-28(34)15-23(17-35-29)30(40)36-16-22-4-7-26(32)27(33)14-22/h2-7,14-15,17,20,25H,8-13,16,18-19H2,1H3,(H,36,40) QCTSPULDYKATSX-UHFFFAOYSA-N 50337220 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-2-methylpiperazin-1-yl)-N-(3,4-dichlorobenzyl)nicotinamide::CHEMBL1681851 C-X-C chemokine receptor type 3 Homo sapiens 39 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337220&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53319879 125087322 CHEMBL1681851 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624246 C[C@@H]1CN(CCN1c1ncc(cc1Cl)C(=O)NCc1ccc(Cl)c(Cl)c1)C1CCN(Cc2ccc(Cl)cc2)CC1 |r| InChI=1S/C30H33Cl4N5O/c1-20-18-38(25-8-10-37(11-9-25)19-21-2-5-24(31)6-3-21)12-13-39(20)29-28(34)15-23(17-35-29)30(40)36-16-22-4-7-26(32)27(33)14-22/h2-7,14-15,17,20,25H,8-13,16,18-19H2,1H3,(H,36,40) QCTSPULDYKATSX-UHFFFAOYSA-N 50337221 (3R)-4-(4-(4-(3,4-dimethylphenyl)but-1-en-2-yl)-2-methylphenyl)-3-methyl-4'-(4-methylbenzyl)bi(cyclohexane)::CHEMBL1681852 C-X-C chemokine receptor type 3 Homo sapiens 220 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337221 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337221&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53326434 125087323 CHEMBL1681852 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624247 CC1CN(CCN1c1ccc(cn1)C(=O)NCc1ccc(F)c(F)c1)C1CCN(Cc2ccc(Cl)cc2)CC1 InChI=1S/C30H34ClF2N5O/c1-21-19-37(26-10-12-36(13-11-26)20-22-2-6-25(31)7-3-22)14-15-38(21)29-9-5-24(18-34-29)30(39)35-17-23-4-8-27(32)28(33)16-23/h2-9,16,18,21,26H,10-15,17,19-20H2,1H3,(H,35,39) NLIKRVUFEZIMOB-UHFFFAOYSA-N 50337222 6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-2-methylpiperazin-1-yl)-N-(3,4-difluorobenzyl)nicotinamide::CHEMBL1681853 C-X-C chemokine receptor type 3 Homo sapiens 2700 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337222 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337222&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53322505 125087324 CHEMBL1681853 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624248 CNC(=O)c1cnc(N2CCN(CC2)C2CCN(Cc3ccc(Cl)cc3)CC2C)c(Cl)c1 InChI=1S/C24H31Cl2N5O/c1-17-15-29(16-18-3-5-20(25)6-4-18)8-7-22(17)30-9-11-31(12-10-30)23-21(26)13-19(14-28-23)24(32)27-2/h3-6,13-14,17,22H,7-12,15-16H2,1-2H3,(H,27,32) GTDDHUPTJCXBTB-UHFFFAOYSA-N 50337223 5-chloro-6-(4-(1-(4-chlorobenzyl)-3-methylpiperidin-4-yl)piperazin-1-yl)-N-methylnicotinamide::CHEMBL1681854 C-X-C chemokine receptor type 3 Homo sapiens 64 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337223 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337223&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53319880 125087325 CHEMBL1681854 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624249 CNC(=O)c1cnc(N2CCN(CC2)C2CCN(Cc3ccc(Cl)cc3)[C@@H](C)C2)c(Cl)c1 |r| InChI=1S/C24H31Cl2N5O/c1-17-13-21(7-8-31(17)16-18-3-5-20(25)6-4-18)29-9-11-30(12-10-29)23-22(26)14-19(15-28-23)24(32)27-2/h3-6,14-15,17,21H,7-13,16H2,1-2H3,(H,27,32) JFLKYMMSUKNRQT-UHFFFAOYSA-N 50301330 5-chloro-6-(4-((2S)-1-(4-chlorobenzyl)-2-methylpiperidin-4-yl)piperazin-1-yl)-N-methylnicotinamide::CHEMBL569117 C-X-C chemokine receptor type 3 Homo sapiens 31 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50301330 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50301330&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 45485437 104155691 CHEMBL569117 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624250 CC1(CCN(Cc2ccc(Cl)cc2)CC1)N1CCN(CC1)c1ncc(cc1Cl)C(=O)NCc1ccc(Cl)c(Cl)c1 InChI=1S/C30H33Cl4N5O/c1-30(8-10-37(11-9-30)20-21-2-5-24(31)6-3-21)39-14-12-38(13-15-39)28-27(34)17-23(19-35-28)29(40)36-18-22-4-7-25(32)26(33)16-22/h2-7,16-17,19H,8-15,18,20H2,1H3,(H,36,40) QXHNFTXJKOORIT-UHFFFAOYSA-N 50337224 5-chloro-6-(4-(1-(4-chlorobenzyl)-4-methylpiperidin-4-yl)piperazin-1-yl)-N-(3,4-dichlorobenzyl)nicotinamide::CHEMBL1681856 C-X-C chemokine receptor type 3 Homo sapiens 27 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337224 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337224&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53322506 125087326 CHEMBL1681856 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624251 Fc1ccc(CNC(=O)c2cnc(N3CCN(C4CCN(Cc5ccc(Cl)cc5)CC4)C(=O)C3)c(Cl)c2)cc1F InChI=1S/C29H29Cl2F2N5O2/c30-22-4-1-19(2-5-22)17-36-9-7-23(8-10-36)38-12-11-37(18-27(38)39)28-24(31)14-21(16-34-28)29(40)35-15-20-3-6-25(32)26(33)13-20/h1-6,13-14,16,23H,7-12,15,17-18H2,(H,35,40) MOBHWRKIMRTYIU-UHFFFAOYSA-N 50337225 5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-oxopiperazin-1-yl)-N-(3,4-difluorobenzyl)nicotinamide::CHEMBL1681857 C-X-C chemokine receptor type 3 Homo sapiens 1400 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337225 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337225&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53325131 125087327 CHEMBL1681857 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624252 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(Cc3ccc(Cl)cc3)C(=O)C2)c(Cl)c1 |r| InChI=1S/C24H29Cl2N5O2/c1-16-14-30(23-21(26)11-18(13-28-23)24(33)27-2)9-10-31(16)20-7-8-29(22(32)12-20)15-17-3-5-19(25)6-4-17/h3-6,11,13,16,20H,7-10,12,14-15H2,1-2H3,(H,27,33) ASJOUHJGEOKEFO-UHFFFAOYSA-N 50337226 5-chloro-6-((3S)-4-(1-(4-chlorobenzyl)-2-oxopiperidin-4-yl)-3-methylpiperazin-1-yl)-N-methylnicotinamide::CHEMBL1681858 C-X-C chemokine receptor type 3 Homo sapiens 7000 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337226&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53318561 125087328 CHEMBL1681858 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624253 Clc1ccc(CN2CCN(CC2)C2CCN(CC2)c2ncc(cc2Cl)C(=O)NCc2ccc(Cl)c(Cl)c2)cc1 InChI=1S/C29H31Cl4N5O/c30-23-4-1-20(2-5-23)19-36-11-13-37(14-12-36)24-7-9-38(10-8-24)28-27(33)16-22(18-34-28)29(39)35-17-21-3-6-25(31)26(32)15-21/h1-6,15-16,18,24H,7-14,17,19H2,(H,35,39) FEYQUORVTPSCPR-UHFFFAOYSA-N 50301332 5-chloro-6-(4-(4-(4-chlorobenzyl)piperazin-1-yl)piperidin-1-yl)-N-(3,4-dichlorobenzyl)nicotinamide::CHEMBL570509 C-X-C chemokine receptor type 3 Homo sapiens 4500 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50301332 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50301332&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 45485420 104155693 CHEMBL570509 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624254 CNC(=O)c1cnc(N2CCC(CC2)N2CCN(Cc3ccc(Cl)cc3)C[C@@H]2C)c(Cl)c1 |r| InChI=1S/C24H31Cl2N5O/c1-17-15-29(16-18-3-5-20(25)6-4-18)11-12-31(17)21-7-9-30(10-8-21)23-22(26)13-19(14-28-23)24(32)27-2/h3-6,13-14,17,21H,7-12,15-16H2,1-2H3,(H,27,32) IQVJJNWVTJZCFF-UHFFFAOYSA-N 50337227 (S)-5-chloro-6-(4-(4-(4-chlorobenzyl)-2-methylpiperazin-1-yl)piperidin-1-yl)-N-methylnicotinamide::CHEMBL1681859 C-X-C chemokine receptor type 3 Homo sapiens 12500 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337227 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337227&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53325132 125087329 CHEMBL1681859 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624255 CNC(=O)c1cnc(N2CCC(CC2)N2CCN(Cc3ccc(Cl)cc3)C[C@H]2C)c(Cl)c1 |r| InChI=1S/C24H31Cl2N5O/c1-17-15-29(16-18-3-5-20(25)6-4-18)11-12-31(17)21-7-9-30(10-8-21)23-22(26)13-19(14-28-23)24(32)27-2/h3-6,13-14,17,21H,7-12,15-16H2,1-2H3,(H,27,32) IQVJJNWVTJZCFF-UHFFFAOYSA-N 50337228 (R)-5-chloro-6-(4-(4-(4-chlorobenzyl)-2-methylpiperazin-1-yl)piperidin-1-yl)-N-methylnicotinamide::CHEMBL1681860 C-X-C chemokine receptor type 3 Homo sapiens 7350 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337228 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337228&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53322507 125087330 CHEMBL1681860 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624256 CNC(=O)c1cnc(N2CCC(C(C)C2)N2CCN(Cc3ccc(Cl)cc3)CC2)c(Cl)c1 InChI=1S/C24H31Cl2N5O/c1-17-15-31(23-21(26)13-19(14-28-23)24(32)27-2)8-7-22(17)30-11-9-29(10-12-30)16-18-3-5-20(25)6-4-18/h3-6,13-14,17,22H,7-12,15-16H2,1-2H3,(H,27,32) FDEHWDMXJMRSQO-UHFFFAOYSA-N 50337229 5-chloro-6-(4-(4-(4-chlorobenzyl)piperazin-1-yl)-3-methylpiperidin-1-yl)-N-methylnicotinamide::CHEMBL1681861 C-X-C chemokine receptor type 3 Homo sapiens 280 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337229 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337229&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53318562 125087331 CHEMBL1681861 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624257 C[C@H]1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(cc1Cl)C(C)=O |r| InChI=1S/C24H30Cl2N4O/c1-17-15-29(24-23(26)13-20(14-27-24)18(2)31)11-12-30(17)22-7-9-28(10-8-22)16-19-3-5-21(25)6-4-19/h3-6,13-14,17,22H,7-12,15-16H2,1-2H3 TXTATRPTHNQBJC-UHFFFAOYSA-N 50337230 (S)-1-(5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)pyridin-3-yl)ethanone::CHEMBL1681862 C-X-C chemokine receptor type 3 Homo sapiens 520 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337230 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337230&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53317275 125087332 CHEMBL1681862 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624258 C[C@H]1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(cc1Cl)C(N)=N |r| InChI=1S/C23H30Cl2N6/c1-16-14-30(23-21(25)12-18(13-28-23)22(26)27)10-11-31(16)20-6-8-29(9-7-20)15-17-2-4-19(24)5-3-17/h2-5,12-13,16,20H,6-11,14-15H2,1H3,(H3,26,27) CYLDPHMITYTBEQ-UHFFFAOYSA-N 50337231 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)nicotinimidamide::CHEMBL1681863 C-X-C chemokine receptor type 3 Homo sapiens 80 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337231 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337231&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53325133 125087333 CHEMBL1681863 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624259 CCNC(=N)c1cnc(N2CCN([C@@H](C)C2)C2CCN(Cc3ccc(Cl)cc3)CC2)c(Cl)c1 |r| InChI=1S/C25H34Cl2N6/c1-3-29-24(28)20-14-23(27)25(30-15-20)32-12-13-33(18(2)16-32)22-8-10-31(11-9-22)17-19-4-6-21(26)7-5-19/h4-7,14-15,18,22H,3,8-13,16-17H2,1-2H3,(H2,28,29) WBNFGMNGUIDTRV-UHFFFAOYSA-N 50337232 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-ethylnicotinimidamide::CHEMBL1681864 C-X-C chemokine receptor type 3 Homo sapiens 83 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337232&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53317663 125087334 CHEMBL1681864 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624260 C[C@H]1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(NC(C)=O)cc1Cl |r| InChI=1S/C24H31Cl2N5O/c1-17-15-30(24-23(26)13-21(14-27-24)28-18(2)32)11-12-31(17)22-7-9-29(10-8-22)16-19-3-5-20(25)6-4-19/h3-6,13-14,17,22H,7-12,15-16H2,1-2H3,(H,28,32) FJPRMZQKEZIPFN-UHFFFAOYSA-N 50337233 (S)-N-(5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)pyridin-3-yl)acetamide::CHEMBL1681865 C-X-C chemokine receptor type 3 Homo sapiens 8 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337233 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337233&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53322508 125087335 CHEMBL1681865 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624261 C[C@H]1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(NC(=O)C2CC2)cc1Cl |r| InChI=1S/C26H33Cl2N5O/c1-18-16-32(25-24(28)14-22(15-29-25)30-26(34)20-4-5-20)12-13-33(18)23-8-10-31(11-9-23)17-19-2-6-21(27)7-3-19/h2-3,6-7,14-15,18,20,23H,4-5,8-13,16-17H2,1H3,(H,30,34) KJKLZLSLVMCEOZ-UHFFFAOYSA-N 50337234 (S)-N-(5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)pyridin-3-yl)cyclopropanecarboxamide::CHEMBL1681866 C-X-C chemokine receptor type 3 Homo sapiens 20 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337234 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337234&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53319881 125087336 CHEMBL1681866 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624262 C[C@H]1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(cc1Cl)C(N)=O |r| InChI=1S/C23H29Cl2N5O/c1-16-14-29(23-21(25)12-18(13-27-23)22(26)31)10-11-30(16)20-6-8-28(9-7-20)15-17-2-4-19(24)5-3-17/h2-5,12-13,16,20H,6-11,14-15H2,1H3,(H2,26,31) VUFZRRBDIQMYNW-UHFFFAOYSA-N 50337235 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)nicotinamide::CHEMBL1681867 C-X-C chemokine receptor type 3 Homo sapiens 39 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337235 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337235&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53321184 125087337 CHEMBL1681867 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624263 CCNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(Cc3ccc(Cl)cc3)CC2)c(Cl)c1 |r| InChI=1S/C25H33Cl2N5O/c1-3-28-25(33)20-14-23(27)24(29-15-20)31-12-13-32(18(2)16-31)22-8-10-30(11-9-22)17-19-4-6-21(26)7-5-19/h4-7,14-15,18,22H,3,8-13,16-17H2,1-2H3,(H,28,33) AHGWRVSBIUYYIH-UHFFFAOYSA-N 50337236 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-ethylnicotinamide::CHEMBL1681868 C-X-C chemokine receptor type 3 Homo sapiens 2.3 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337236 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337236&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53322509 125087338 CHEMBL1681868 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624264 CC(C)NC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(Cc3ccc(Cl)cc3)CC2)c(Cl)c1 |r| InChI=1S/C26H35Cl2N5O/c1-18(2)30-26(34)21-14-24(28)25(29-15-21)32-12-13-33(19(3)16-32)23-8-10-31(11-9-23)17-20-4-6-22(27)7-5-20/h4-7,14-15,18-19,23H,8-13,16-17H2,1-3H3,(H,30,34) CYQGUVORQGVFTP-UHFFFAOYSA-N 50337237 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-isopropylnicotinamide::CHEMBL1681869 C-X-C chemokine receptor type 3 Homo sapiens 5 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337237 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337237&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53321185 125087339 CHEMBL1681869 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624265 C[C@H]1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(cc1Cl)C(=O)NCC1CCCCC1 |r| InChI=1S/C30H41Cl2N5O/c1-22-20-36(29-28(32)17-25(19-33-29)30(38)34-18-23-5-3-2-4-6-23)15-16-37(22)27-11-13-35(14-12-27)21-24-7-9-26(31)10-8-24/h7-10,17,19,22-23,27H,2-6,11-16,18,20-21H2,1H3,(H,34,38) MTDWSEHSHFRGKO-UHFFFAOYSA-N 50337238 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-(cyclohexylmethyl)nicotinamide::CHEMBL1681870 C-X-C chemokine receptor type 3 Homo sapiens 2.4 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337238 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337238&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53317276 125087340 CHEMBL1681870 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624266 C[C@H]1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(cc1Cl)C(=O)Nc1ccc(F)c(F)c1 |r| InChI=1S/C29H31Cl2F2N5O/c1-19-17-37(12-13-38(19)24-8-10-36(11-9-24)18-20-2-4-22(30)5-3-20)28-25(31)14-21(16-34-28)29(39)35-23-6-7-26(32)27(33)15-23/h2-7,14-16,19,24H,8-13,17-18H2,1H3,(H,35,39) WCMRUXPJUJQVRU-UHFFFAOYSA-N 50337239 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-(3,4-difluorophenyl)nicotinamide::CHEMBL1681871 C-X-C chemokine receptor type 3 Homo sapiens 22 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337239 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337239&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53317277 125087341 CHEMBL1681871 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624267 C[C@H]1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(cc1Cl)C(=O)N1CCCCC1 |r| InChI=1S/C28H37Cl2N5O/c1-21-19-34(27-26(30)17-23(18-31-27)28(36)33-11-3-2-4-12-33)15-16-35(21)25-9-13-32(14-10-25)20-22-5-7-24(29)8-6-22/h5-8,17-18,21,25H,2-4,9-16,19-20H2,1H3 ZCWZXRIDERBDQN-UHFFFAOYSA-N 50337240 (S)-(5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)pyridin-3-yl)(piperidin-1-yl)methanone::CHEMBL1681872 C-X-C chemokine receptor type 3 Homo sapiens 900 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337240&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53322510 125087342 CHEMBL1681872 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624268 C[C@H]1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(cc1Cl)C(=O)N1CCC1 |r| InChI=1S/C26H33Cl2N5O/c1-19-17-32(25-24(28)15-21(16-29-25)26(34)31-9-2-10-31)13-14-33(19)23-7-11-30(12-8-23)18-20-3-5-22(27)6-4-20/h3-6,15-16,19,23H,2,7-14,17-18H2,1H3 UZQBZHABMBQUAM-UHFFFAOYSA-N 50337241 (S)-azetidin-1-yl(5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)pyridin-3-yl)methanone::CHEMBL1681873 C-X-C chemokine receptor type 3 Homo sapiens 630 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337241 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337241&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53322511 125087343 CHEMBL1681873 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624269 CC[C@H]1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(cc1Cl)C(=O)NC |r| InChI=1S/C25H33Cl2N5O/c1-3-21-17-31(24-23(27)14-19(15-29-24)25(33)28-2)12-13-32(21)22-8-10-30(11-9-22)16-18-4-6-20(26)7-5-18/h4-7,14-15,21-22H,3,8-13,16-17H2,1-2H3,(H,28,33) VTYZGDIQHRIHEO-UHFFFAOYSA-N 50337242 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-ethylpiperazin-1-yl)-N-methylnicotinamide::CHEMBL1681874 C-X-C chemokine receptor type 3 Homo sapiens 3 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337242 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337242&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53324231 125087344 CHEMBL1681874 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624270 CNC(=O)c1cnc(N2CCN([C@@H](CC(C)C)C2)C2CCN(Cc3ccc(Cl)cc3)CC2)c(Cl)c1 |r| InChI=1S/C27H37Cl2N5O/c1-19(2)14-24-18-33(26-25(29)15-21(16-31-26)27(35)30-3)12-13-34(24)23-8-10-32(11-9-23)17-20-4-6-22(28)7-5-20/h4-7,15-16,19,23-24H,8-14,17-18H2,1-3H3,(H,30,35) OLWIGCQZRLZDLB-UHFFFAOYSA-N 50337243 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-isobutylpiperazin-1-yl)-N-methylnicotinamide::CHEMBL1681875 C-X-C chemokine receptor type 3 Homo sapiens 260 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337243&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53325134 125087345 CHEMBL1681875 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624271 CNC(=O)c1cnc(N2CCN(C3CCN(Cc4ccc(Cl)cc4)CC3)[C@H](C2)c2ccccc2)c(Cl)c1 |r| InChI=1S/C29H33Cl2N5O/c1-32-29(37)23-17-26(31)28(33-18-23)35-15-16-36(27(20-35)22-5-3-2-4-6-22)25-11-13-34(14-12-25)19-21-7-9-24(30)10-8-21/h2-10,17-18,25,27H,11-16,19-20H2,1H3,(H,32,37) BQGPSOUAQNSHSM-UHFFFAOYSA-N 50337244 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-phenylpiperazin-1-yl)-N-methylnicotinamide::CHEMBL1681876 C-X-C chemokine receptor type 3 Homo sapiens 830 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337244 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337244&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53318914 125087346 CHEMBL1681876 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624272 CNC(=O)c1cnc(N2CCN(C3CCN(Cc4ccc(Cl)cc4)CC3)C(C2)C(=O)OC)c(Cl)c1 InChI=1S/C25H31Cl2N5O3/c1-28-24(33)18-13-21(27)23(29-14-18)31-11-12-32(22(16-31)25(34)35-2)20-7-9-30(10-8-20)15-17-3-5-19(26)6-4-17/h3-6,13-14,20,22H,7-12,15-16H2,1-2H3,(H,28,33) ZVQHEZKGRFHDCT-UHFFFAOYSA-N 50337245 methyl 4-(3-chloro-5-(methylcarbamoyl)pyridin-2-yl)-1-(1-(4-chlorobenzyl)piperidin-4-yl)piperazine-2-carboxylate::CHEMBL1681877 C-X-C chemokine receptor type 3 Homo sapiens 140 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337245 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337245&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53323853 125087347 CHEMBL1681877 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624273 CNC(=O)c1cnc(N2CCN(C(CO)C2)C2CCN(Cc3ccc(Cl)cc3)CC2)c(Cl)c1 InChI=1S/C24H31Cl2N5O2/c1-27-24(33)18-12-22(26)23(28-13-18)30-10-11-31(21(15-30)16-32)20-6-8-29(9-7-20)14-17-2-4-19(25)5-3-17/h2-5,12-13,20-21,32H,6-11,14-16H2,1H3,(H,27,33) PONAOOISGRZJDD-UHFFFAOYSA-N 50337246 5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-(hydroxymethyl)piperazin-1-yl)-N-methylnicotinamide::CHEMBL1681878 C-X-C chemokine receptor type 3 Homo sapiens 910 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337246 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337246&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53323854 125087348 CHEMBL1681878 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624274 CNC(=O)c1cnc(N2CCN(C(COC)C2)C2CCN(Cc3ccc(Cl)cc3)CC2)c(Cl)c1 InChI=1S/C25H33Cl2N5O2/c1-28-25(33)19-13-23(27)24(29-14-19)31-11-12-32(22(16-31)17-34-2)21-7-9-30(10-8-21)15-18-3-5-20(26)6-4-18/h3-6,13-14,21-22H,7-12,15-17H2,1-2H3,(H,28,33) QQLBKYNSZMSSMU-UHFFFAOYSA-N 50337247 5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-(methoxymethyl)piperazin-1-yl)-N-methylnicotinamide::CHEMBL1681879 C-X-C chemokine receptor type 3 Homo sapiens 3100 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337247&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53321186 125087349 CHEMBL1681879 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624275 CNC(=O)c1cnc(N2CCN(C3CCN(Cc4ccc(Cl)cc4)CC3)C(C2)C(O)=O)c(Cl)c1 InChI=1S/C24H29Cl2N5O3/c1-27-23(32)17-12-20(26)22(28-13-17)30-10-11-31(21(15-30)24(33)34)19-6-8-29(9-7-19)14-16-2-4-18(25)5-3-16/h2-5,12-13,19,21H,6-11,14-15H2,1H3,(H,27,32)(H,33,34) CIRUTWSJCAALLH-UHFFFAOYSA-N 50337248 4-(3-chloro-5-(methylcarbamoyl)pyridin-2-yl)-1-(1-(4-chlorobenzyl)piperidin-4-yl)piperazine-2-carboxylic acid::CHEMBL1681880 C-X-C chemokine receptor type 3 Homo sapiens >50000 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337248&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53324328 125087350 CHEMBL1681880 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624276 CNOC(=O)C1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(cc1Cl)C(=O)NC InChI=1S/C25H32Cl2N6O3/c1-28-24(34)18-13-21(27)23(30-14-18)32-11-12-33(22(16-32)25(35)36-29-2)20-7-9-31(10-8-20)15-17-3-5-19(26)6-4-17/h3-6,13-14,20,22,29H,7-12,15-16H2,1-2H3,(H,28,34) WRRYTLCILFNRJB-UHFFFAOYSA-N 50337249 5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-((methylaminooxy)carbonyl)piperazin-1-yl)-N-methylnicotinamide::CHEMBL1681881 C-X-C chemokine receptor type 3 Homo sapiens 8900 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337249&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53318563 125087351 CHEMBL1681881 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624277 CCNC(=O)c1cnc(N2CCN([C@@H](CC)C2)C2CCN(Cc3ccc(Cl)cc3)CC2)c(Cl)c1 |r| InChI=1S/C26H35Cl2N5O/c1-3-22-18-32(25-24(28)15-20(16-30-25)26(34)29-4-2)13-14-33(22)23-9-11-31(12-10-23)17-19-5-7-21(27)8-6-19/h5-8,15-16,22-23H,3-4,9-14,17-18H2,1-2H3,(H,29,34) XQWKNLJIWOTOKT-UHFFFAOYSA-N 50337250 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-ethylpiperazin-1-yl)-N-ethylnicotinamide::CHEMBL472288 C-X-C chemokine receptor type 3 Homo sapiens 0.3 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337250&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 44592137 125087352 CHEMBL472288 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624278 CCNC(=O)c1cnc(N2CCN([C@@H](CC)C2)C2CCN(Cc3ccc(Cl)cc3F)CC2)c(Cl)c1 |r| InChI=1S/C26H34Cl2FN5O/c1-3-21-17-33(25-23(28)13-19(15-31-25)26(35)30-4-2)11-12-34(21)22-7-9-32(10-8-22)16-18-5-6-20(27)14-24(18)29/h5-6,13-15,21-22H,3-4,7-12,16-17H2,1-2H3,(H,30,35) LXEUJQNDOXTGHH-UHFFFAOYSA-N 50337251 (S)-5-chloro-6-(4-(1-(4-chloro-2-fluorobenzyl)piperidin-4-yl)-3-ethylpiperazin-1-yl)-N-ethylnicotinamide::CHEMBL1681882 C-X-C chemokine receptor type 3 Homo sapiens 0.2 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337251&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 11569938 125087353 CHEMBL1681882 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624279 CCNC(=O)c1cnc(N2CCN(C3CCN(Cc4ccc(Cl)cc4)CC3)[C@H](C2)C(C)C)c(Cl)c1 |r| InChI=1S/C27H37Cl2N5O/c1-4-30-27(35)21-15-24(29)26(31-16-21)33-13-14-34(25(18-33)19(2)3)23-9-11-32(12-10-23)17-20-5-7-22(28)8-6-20/h5-8,15-16,19,23,25H,4,9-14,17-18H2,1-3H3,(H,30,35) QQJVZFZRQQUWOC-UHFFFAOYSA-N 50337252 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-isopropylpiperazin-1-yl)-N-ethylnicotinamide::CHEMBL1681883 C-X-C chemokine receptor type 3 Homo sapiens 23 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337252&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53321187 125087354 CHEMBL1681883 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624280 CCNC(=O)c1cnc(N2CCN(C3CCN(Cc4ccc(Cl)cc4F)CC3)C(C2)C2CC2)c(Cl)c1 InChI=1S/C27H34Cl2FN5O/c1-2-31-27(36)20-13-23(29)26(32-15-20)34-11-12-35(25(17-34)18-3-4-18)22-7-9-33(10-8-22)16-19-5-6-21(28)14-24(19)30/h5-6,13-15,18,22,25H,2-4,7-12,16-17H2,1H3,(H,31,36) BNSISGSQGFUVIN-UHFFFAOYSA-N 50337253 5-chloro-6-(4-(1-(4-chloro-2-fluorobenzyl)piperidin-4-yl)-3-cyclopropylpiperazin-1-yl)-N-ethylnicotinamide::CHEMBL1681884 C-X-C chemokine receptor type 3 Homo sapiens 32 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337253&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53319882 125087355 CHEMBL1681884 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624281 Fc1ccc(CNC(=O)c2cnc(N3CCN(CC3)C3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)c2)cc1F InChI=1S/C29H31Cl2F2N5O/c30-23-4-1-20(2-5-23)19-36-9-7-24(8-10-36)37-11-13-38(14-12-37)28-25(31)16-22(18-34-28)29(39)35-17-21-3-6-26(32)27(33)15-21/h1-6,15-16,18,24H,7-14,17,19H2,(H,35,39) FMYKWJDOTAPBPQ-UHFFFAOYSA-N 50337217 5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)piperazin-1-yl)-N-(3,4-difluorobenzyl)nicotinamide::CHEMBL1681848 C-X-C chemokine receptor type 3 Mus musculus 84 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003604&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337217&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53322504 125087319 CHEMBL1681848 1 MYLEVSERQVLDASDFAFLLENSTSPYDYGENESDFSDSPPCPQDFSLNFDRTFLPALYSLLFLLGLLGNGAVAAVLLSQRTALSSTDTFLLHLAVADVLLVLTLPLWAVDAAVQWVFGPGLCKVAGALFNINFYAGAFLLACISFDRYLSIVHATQIYRRDPRVRVALTCIVVWGLCLLFALPDFIYLSANYDQRLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRFRAMRLVVVVVAAFAVCWTPYHLVVLVDILMDVGVLARNCGRESHVDVAKSVTSGMGYMHCCLNPLLYAFVGVKFREQMWMLFTRLGRSDQRGPQRQPSSSRRESSWSETTEASYLGL 8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_MOUSE O88410 Q4V9Y6 Q9QWN6 50624282 C[C@H]1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(cc1Cl)C(=O)NCc1ccc(F)c(F)c1 |r| InChI=1S/C30H33Cl2F2N5O/c1-20-18-38(12-13-39(20)25-8-10-37(11-9-25)19-21-2-5-24(31)6-3-21)29-26(32)15-23(17-35-29)30(40)36-16-22-4-7-27(33)28(34)14-22/h2-7,14-15,17,20,25H,8-13,16,18-19H2,1H3,(H,36,40) KXOXGMSSGWQNPP-UHFFFAOYSA-N 50337218 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-(3,4-difluorobenzyl)nicotinamide::CHEMBL1681849 C-X-C chemokine receptor type 3 Mus musculus 6.7 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003604&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337218&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53318560 125087320 CHEMBL1681849 1 MYLEVSERQVLDASDFAFLLENSTSPYDYGENESDFSDSPPCPQDFSLNFDRTFLPALYSLLFLLGLLGNGAVAAVLLSQRTALSSTDTFLLHLAVADVLLVLTLPLWAVDAAVQWVFGPGLCKVAGALFNINFYAGAFLLACISFDRYLSIVHATQIYRRDPRVRVALTCIVVWGLCLLFALPDFIYLSANYDQRLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRFRAMRLVVVVVAAFAVCWTPYHLVVLVDILMDVGVLARNCGRESHVDVAKSVTSGMGYMHCCLNPLLYAFVGVKFREQMWMLFTRLGRSDQRGPQRQPSSSRRESSWSETTEASYLGL 8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_MOUSE O88410 Q4V9Y6 Q9QWN6 50624283 CCNC(=O)c1cnc(N2CCN([C@@H](CC)C2)C2CCN(Cc3ccc(Cl)cc3)CC2)c(Cl)c1 |r| InChI=1S/C26H35Cl2N5O/c1-3-22-18-32(25-24(28)15-20(16-30-25)26(34)29-4-2)13-14-33(22)23-9-11-31(12-10-23)17-19-5-7-21(27)8-6-19/h5-8,15-16,22-23H,3-4,9-14,17-18H2,1-2H3,(H,29,34) XQWKNLJIWOTOKT-UHFFFAOYSA-N 50337250 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-ethylpiperazin-1-yl)-N-ethylnicotinamide::CHEMBL472288 C-X-C chemokine receptor type 3 Mus musculus 0.5 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003604&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337250&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 44592137 125087352 CHEMBL472288 1 MYLEVSERQVLDASDFAFLLENSTSPYDYGENESDFSDSPPCPQDFSLNFDRTFLPALYSLLFLLGLLGNGAVAAVLLSQRTALSSTDTFLLHLAVADVLLVLTLPLWAVDAAVQWVFGPGLCKVAGALFNINFYAGAFLLACISFDRYLSIVHATQIYRRDPRVRVALTCIVVWGLCLLFALPDFIYLSANYDQRLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRFRAMRLVVVVVAAFAVCWTPYHLVVLVDILMDVGVLARNCGRESHVDVAKSVTSGMGYMHCCLNPLLYAFVGVKFREQMWMLFTRLGRSDQRGPQRQPSSSRRESSWSETTEASYLGL 8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_MOUSE O88410 Q4V9Y6 Q9QWN6 50624284 CCNC(=O)c1cnc(N2CCN([C@@H](CC)C2)C2CCN(Cc3ccc(Cl)cc3F)CC2)c(Cl)c1 |r| InChI=1S/C26H34Cl2FN5O/c1-3-21-17-33(25-23(28)13-19(15-31-25)26(35)30-4-2)11-12-34(21)22-7-9-32(10-8-22)16-18-5-6-20(27)14-24(18)29/h5-6,13-15,21-22H,3-4,7-12,16-17H2,1-2H3,(H,30,35) LXEUJQNDOXTGHH-UHFFFAOYSA-N 50337251 (S)-5-chloro-6-(4-(1-(4-chloro-2-fluorobenzyl)piperidin-4-yl)-3-ethylpiperazin-1-yl)-N-ethylnicotinamide::CHEMBL1681882 C-X-C chemokine receptor type 3 Mus musculus 1.1 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003604&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337251&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 11569938 125087353 CHEMBL1681882 1 MYLEVSERQVLDASDFAFLLENSTSPYDYGENESDFSDSPPCPQDFSLNFDRTFLPALYSLLFLLGLLGNGAVAAVLLSQRTALSSTDTFLLHLAVADVLLVLTLPLWAVDAAVQWVFGPGLCKVAGALFNINFYAGAFLLACISFDRYLSIVHATQIYRRDPRVRVALTCIVVWGLCLLFALPDFIYLSANYDQRLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRFRAMRLVVVVVAAFAVCWTPYHLVVLVDILMDVGVLARNCGRESHVDVAKSVTSGMGYMHCCLNPLLYAFVGVKFREQMWMLFTRLGRSDQRGPQRQPSSSRRESSWSETTEASYLGL 8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_MOUSE O88410 Q4V9Y6 Q9QWN6 50624285 Fc1ccc(CNC(=O)c2cnc(N3CCN(CC3)C3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)c2)cc1F InChI=1S/C29H31Cl2F2N5O/c30-23-4-1-20(2-5-23)19-36-9-7-24(8-10-36)37-11-13-38(14-12-37)28-25(31)16-22(18-34-28)29(39)35-17-21-3-6-26(32)27(33)15-21/h1-6,15-16,18,24H,7-14,17,19H2,(H,35,39) FMYKWJDOTAPBPQ-UHFFFAOYSA-N 50337217 5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)piperazin-1-yl)-N-(3,4-difluorobenzyl)nicotinamide::CHEMBL1681848 C-X-C chemokine receptor type 3 Rattus norvegicus 97 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004441&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337217&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53322504 125087319 CHEMBL1681848 1 MYLEVSERQVLDASDIAFLLENSTSPYDYGENESDFSDSPPCPQDFSLNFDRTFLPVLYSLLFLLGLLGNGAVAAVLLSQRTALSSTDTFLLHLAVADVLLVLTLPLWAVDAAAQWVFGSGLCKVAGALFNINFYAGAFLLACISFDRYLSIVHATQIYRRDPWVRVALTCIVVWGLCVLFALPDFIFLSASHDQRLNATHCQYNFPQVGRTALRVLQLVAGFLMPLLVMAYCYAHILAVLLVSRGQRRFRAMRLVVVVVVAFAVCWTPYHLVVLVDILMDVGVLARNCGRESHVDVAKSVTSGMGYMHCCLNPLLYAFVGVKFKEQMWMLLMRLGRSDQRGPQRQPSSSRRESSWSETTEASYLGL 8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_RAT Q9JII9 50624286 C[C@H]1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(cc1Cl)C(=O)NCc1ccc(F)c(F)c1 |r| InChI=1S/C30H33Cl2F2N5O/c1-20-18-38(12-13-39(20)25-8-10-37(11-9-25)19-21-2-5-24(31)6-3-21)29-26(32)15-23(17-35-29)30(40)36-16-22-4-7-27(33)28(34)14-22/h2-7,14-15,17,20,25H,8-13,16,18-19H2,1H3,(H,36,40) KXOXGMSSGWQNPP-UHFFFAOYSA-N 50337218 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-(3,4-difluorobenzyl)nicotinamide::CHEMBL1681849 C-X-C chemokine receptor type 3 Rattus norvegicus 9.9 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004441&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337218&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53318560 125087320 CHEMBL1681849 1 MYLEVSERQVLDASDIAFLLENSTSPYDYGENESDFSDSPPCPQDFSLNFDRTFLPVLYSLLFLLGLLGNGAVAAVLLSQRTALSSTDTFLLHLAVADVLLVLTLPLWAVDAAAQWVFGSGLCKVAGALFNINFYAGAFLLACISFDRYLSIVHATQIYRRDPWVRVALTCIVVWGLCVLFALPDFIFLSASHDQRLNATHCQYNFPQVGRTALRVLQLVAGFLMPLLVMAYCYAHILAVLLVSRGQRRFRAMRLVVVVVVAFAVCWTPYHLVVLVDILMDVGVLARNCGRESHVDVAKSVTSGMGYMHCCLNPLLYAFVGVKFKEQMWMLLMRLGRSDQRGPQRQPSSSRRESSWSETTEASYLGL 8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_RAT Q9JII9 50624287 CCNC(=O)c1cnc(N2CCN([C@@H](CC)C2)C2CCN(Cc3ccc(Cl)cc3)CC2)c(Cl)c1 |r| InChI=1S/C26H35Cl2N5O/c1-3-22-18-32(25-24(28)15-20(16-30-25)26(34)29-4-2)13-14-33(22)23-9-11-31(12-10-23)17-19-5-7-21(27)8-6-19/h5-8,15-16,22-23H,3-4,9-14,17-18H2,1-2H3,(H,29,34) XQWKNLJIWOTOKT-UHFFFAOYSA-N 50337250 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-ethylpiperazin-1-yl)-N-ethylnicotinamide::CHEMBL472288 C-X-C chemokine receptor type 3 Rattus norvegicus 1.2 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004441&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337250&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 44592137 125087352 CHEMBL472288 1 MYLEVSERQVLDASDIAFLLENSTSPYDYGENESDFSDSPPCPQDFSLNFDRTFLPVLYSLLFLLGLLGNGAVAAVLLSQRTALSSTDTFLLHLAVADVLLVLTLPLWAVDAAAQWVFGSGLCKVAGALFNINFYAGAFLLACISFDRYLSIVHATQIYRRDPWVRVALTCIVVWGLCVLFALPDFIFLSASHDQRLNATHCQYNFPQVGRTALRVLQLVAGFLMPLLVMAYCYAHILAVLLVSRGQRRFRAMRLVVVVVVAFAVCWTPYHLVVLVDILMDVGVLARNCGRESHVDVAKSVTSGMGYMHCCLNPLLYAFVGVKFKEQMWMLLMRLGRSDQRGPQRQPSSSRRESSWSETTEASYLGL 8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_RAT Q9JII9 50624288 CCNC(=O)c1cnc(N2CCN([C@@H](CC)C2)C2CCN(Cc3ccc(Cl)cc3F)CC2)c(Cl)c1 |r| InChI=1S/C26H34Cl2FN5O/c1-3-21-17-33(25-23(28)13-19(15-31-25)26(35)30-4-2)11-12-34(21)22-7-9-32(10-8-22)16-18-5-6-20(27)14-24(18)29/h5-6,13-15,21-22H,3-4,7-12,16-17H2,1-2H3,(H,30,35) LXEUJQNDOXTGHH-UHFFFAOYSA-N 50337251 (S)-5-chloro-6-(4-(1-(4-chloro-2-fluorobenzyl)piperidin-4-yl)-3-ethylpiperazin-1-yl)-N-ethylnicotinamide::CHEMBL1681882 C-X-C chemokine receptor type 3 Rattus norvegicus 1.6 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004441&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337251&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 11569938 125087353 CHEMBL1681882 1 MYLEVSERQVLDASDIAFLLENSTSPYDYGENESDFSDSPPCPQDFSLNFDRTFLPVLYSLLFLLGLLGNGAVAAVLLSQRTALSSTDTFLLHLAVADVLLVLTLPLWAVDAAAQWVFGSGLCKVAGALFNINFYAGAFLLACISFDRYLSIVHATQIYRRDPWVRVALTCIVVWGLCVLFALPDFIFLSASHDQRLNATHCQYNFPQVGRTALRVLQLVAGFLMPLLVMAYCYAHILAVLLVSRGQRRFRAMRLVVVVVVAFAVCWTPYHLVVLVDILMDVGVLARNCGRESHVDVAKSVTSGMGYMHCCLNPLLYAFVGVKFKEQMWMLLMRLGRSDQRGPQRQPSSSRRESSWSETTEASYLGL 8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_RAT Q9JII9 50624289 C[C@H]1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(cc1Cl)C(=O)NCc1ccc(F)c(F)c1 |r| InChI=1S/C30H33Cl2F2N5O/c1-20-18-38(12-13-39(20)25-8-10-37(11-9-25)19-21-2-5-24(31)6-3-21)29-26(32)15-23(17-35-29)30(40)36-16-22-4-7-27(33)28(34)14-22/h2-7,14-15,17,20,25H,8-13,16,18-19H2,1H3,(H,36,40) KXOXGMSSGWQNPP-UHFFFAOYSA-N 50337218 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-(3,4-difluorobenzyl)nicotinamide::CHEMBL1681849 Cytochrome P450 2D6 Homo sapiens >10000 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=356&target=Cytochrome+P450+2D6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337218&enzyme=Cytochrome+P450+2D6&column=ki&startPg=0&Increment=50&submit=Search 53318560 125087320 CHEMBL1681849 1 MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPR 6CSD,6CSB Cytochrome P450 2D6 CP2D6_HUMAN P10635 Q16752 Q2XND6 Q2XND7 Q2XNE0 Q6B012 Q6NXU8 Cytochrome P450 C1ID52_HUMAN C1ID52 50624290 C[C@H]1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(cc1Cl)C(=O)NCc1ccc(F)c(F)c1 |r| InChI=1S/C30H33Cl2F2N5O/c1-20-18-38(12-13-39(20)25-8-10-37(11-9-25)19-21-2-5-24(31)6-3-21)29-26(32)15-23(17-35-29)30(40)36-16-22-4-7-27(33)28(34)14-22/h2-7,14-15,17,20,25H,8-13,16,18-19H2,1H3,(H,36,40) KXOXGMSSGWQNPP-UHFFFAOYSA-N 50337218 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-(3,4-difluorobenzyl)nicotinamide::CHEMBL1681849 Cytochrome P450 3A4 Homo sapiens >10000 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2127&target=Cytochrome+P450+3A4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337218&enzyme=Cytochrome+P450+3A4&column=ki&startPg=0&Increment=50&submit=Search 53318560 125087320 CHEMBL1681849 1 MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGA 7LXL,3NXU,2V0M,2J0D,1W0G,1W0F,1W0E,9GK1,4NY4 Cytochrome P450 3A4 CP3A4_HUMAN P08684 P05184 Q16757 Q9UK50 Cytochrome P450 3A Q6GRK0_HUMAN Q6GRK0 50624291 C[C@H]1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(cc1Cl)C(=O)NCc1ccc(F)c(F)c1 |r| InChI=1S/C30H33Cl2F2N5O/c1-20-18-38(12-13-39(20)25-8-10-37(11-9-25)19-21-2-5-24(31)6-3-21)29-26(32)15-23(17-35-29)30(40)36-16-22-4-7-27(33)28(34)14-22/h2-7,14-15,17,20,25H,8-13,16,18-19H2,1H3,(H,36,40) KXOXGMSSGWQNPP-UHFFFAOYSA-N 50337218 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-(3,4-difluorobenzyl)nicotinamide::CHEMBL1681849 Cytochrome P450 2C19 Homo sapiens >10000 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2148&target=Cytochrome+P450+2C19&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337218&enzyme=Cytochrome+P450+2C19&column=ki&startPg=0&Increment=50&submit=Search 53318560 125087320 CHEMBL1681849 1 MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDVSKSLTNLSKIYGPVFTLYFGLERMVVLHGYEVVKEALIDLGEEFSGRGHFPLAERANRGFGIVFSNGKRWKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFQKRFDYKDQQFLNLMEKLNENIRIVSTPWIQICNNFPTIIDYFPGTHNKLLKNLAFMESDILEKVKEHQESMDINNPRDFIDCFLIKMEKEKQNQQSEFTIENLVITAADLLGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRGHMPYTDAVVHEVQRYIDLIPTSLPHAVTCDVKFRNYLIPKGTTILTSLTSVLHDNKEFPNPEMFDPRHFLDEGGNFKKSNYFMPFSAGKRICVGEGLARMELFLFLTFILQNFNLKSLIDPKDLDTTPVVNGFASVPPFYQLCFIPV Cytochrome P450 2C19 CP2CJ_HUMAN P33261 P33259 Q8WZB1 Q8WZB2 Q9UCD4 50624292 C[C@H]1CN(CCN1C1CCN(Cc2ccc(Cl)cc2)CC1)c1ncc(cc1Cl)C(=O)NCc1ccc(F)c(F)c1 |r| InChI=1S/C30H33Cl2F2N5O/c1-20-18-38(12-13-39(20)25-8-10-37(11-9-25)19-21-2-5-24(31)6-3-21)29-26(32)15-23(17-35-29)30(40)36-16-22-4-7-27(33)28(34)14-22/h2-7,14-15,17,20,25H,8-13,16,18-19H2,1H3,(H,36,40) KXOXGMSSGWQNPP-UHFFFAOYSA-N 50337218 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-(3,4-difluorobenzyl)nicotinamide::CHEMBL1681849 C-X-C chemokine receptor type 3 Homo sapiens 23 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337218&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53318560 125087320 CHEMBL1681849 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624293 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(Cc3ccc(Cl)cc3)CC2)c(Cl)c1 |r| InChI=1S/C24H31Cl2N5O/c1-17-15-30(23-22(26)13-19(14-28-23)24(32)27-2)11-12-31(17)21-7-9-29(10-8-21)16-18-3-5-20(25)6-4-18/h3-6,13-14,17,21H,7-12,15-16H2,1-2H3,(H,27,32) ONTIDHPPKRWLHM-UHFFFAOYSA-N 50337254 (S)-5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-methylnicotinamide::CHEMBL1681841 C-X-C chemokine receptor type 3 Homo sapiens 32 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337254&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 45101498 125087356 CHEMBL1681841 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624294 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(Cc3ccco3)CC2)c(Cl)c1 |r| InChI=1S/C22H30ClN5O2/c1-16-14-27(21-20(23)12-17(13-25-21)22(29)24-2)9-10-28(16)18-5-7-26(8-6-18)15-19-4-3-11-30-19/h3-4,11-13,16,18H,5-10,14-15H2,1-2H3,(H,24,29) NRFRORKKKVFRAC-UHFFFAOYSA-N 50337255 (S)-5-chloro-6-(4-(1-(furan-2-ylmethyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-methylnicotinamide::CHEMBL1681842 C-X-C chemokine receptor type 3 Homo sapiens 8100 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337255 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337255&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53317216 125087357 CHEMBL1681842 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624295 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(Cc3cccs3)CC2)c(Cl)c1 |r| InChI=1S/C22H30ClN5OS/c1-16-14-27(21-20(23)12-17(13-25-21)22(29)24-2)9-10-28(16)18-5-7-26(8-6-18)15-19-4-3-11-30-19/h3-4,11-13,16,18H,5-10,14-15H2,1-2H3,(H,24,29) CJJZUZJVZHNJER-UHFFFAOYSA-N 50337256 (S)-5-chloro-N-methyl-6-(3-methyl-4-(1-(thiophen-2-ylmethyl)piperidin-4-yl)piperazin-1-yl)nicotinamide::CHEMBL1681840 C-X-C chemokine receptor type 3 Homo sapiens 1980 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337256&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53318512 125087358 CHEMBL1681840 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624296 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(Cc3ccc[nH]3)CC2)c(Cl)c1 |r| InChI=1S/C22H31ClN6O/c1-16-14-28(21-20(23)12-17(13-26-21)22(30)24-2)10-11-29(16)19-5-8-27(9-6-19)15-18-4-3-7-25-18/h3-4,7,12-13,16,19,25H,5-6,8-11,14-15H2,1-2H3,(H,24,30) UIZKJFMZYHBFIB-UHFFFAOYSA-N 50337257 (S)-6-(4-(1-((1H-pyrrol-2-yl)methyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-5-chloro-N-methylnicotinamide::CHEMBL1681839 C-X-C chemokine receptor type 3 Homo sapiens 8060 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337257 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337257&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53322461 125087359 CHEMBL1681839 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624297 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(Cc3ccccn3)CC2)c(Cl)c1 |r| InChI=1S/C23H31ClN6O/c1-17-15-29(22-21(24)13-18(14-27-22)23(31)25-2)11-12-30(17)20-6-9-28(10-7-20)16-19-5-3-4-8-26-19/h3-5,8,13-14,17,20H,6-7,9-12,15-16H2,1-2H3,(H,25,31) ZDFISBSKLYESAY-UHFFFAOYSA-N 50337258 (S)-5-chloro-N-methyl-6-(3-methyl-4-(1-(pyridin-2-ylmethyl)piperidin-4-yl)piperazin-1-yl)nicotinamide::CHEMBL1681838 C-X-C chemokine receptor type 3 Homo sapiens 7990 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337258&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53322974 125087360 CHEMBL1681838 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624298 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(Cc3ccc(cc3)S(C)(=O)=O)CC2)c(Cl)c1 |r| InChI=1S/C25H34ClN5O3S/c1-18-16-30(24-23(26)14-20(15-28-24)25(32)27-2)12-13-31(18)21-8-10-29(11-9-21)17-19-4-6-22(7-5-19)35(3,33)34/h4-7,14-15,18,21H,8-13,16-17H2,1-3H3,(H,27,32) KFWUMCCGHJJHSY-UHFFFAOYSA-N 50337259 (S)-5-chloro-N-methyl-6-(3-methyl-4-(1-(4-(methylsulfonyl)benzyl)piperidin-4-yl)piperazin-1-yl)nicotinamide::CHEMBL1681837 C-X-C chemokine receptor type 3 Homo sapiens >10000 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337259 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337259&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53318511 125087361 CHEMBL1681837 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624299 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(Cc3ccc(C)cc3)CC2)c(Cl)c1 |r| InChI=1S/C25H34ClN5O/c1-18-4-6-20(7-5-18)17-29-10-8-22(9-11-29)31-13-12-30(16-19(31)2)24-23(26)14-21(15-28-24)25(32)27-3/h4-7,14-15,19,22H,8-13,16-17H2,1-3H3,(H,27,32) HTTGJATUZKILNI-UHFFFAOYSA-N 50337260 (S)-5-chloro-N-methyl-6-(3-methyl-4-(1-(4-methylbenzyl)piperidin-4-yl)piperazin-1-yl)nicotinamide::CHEMBL1681836 C-X-C chemokine receptor type 3 Homo sapiens 87 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337260 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337260&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53326389 125087362 CHEMBL1681836 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624300 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(CC2)C(F)(F)F)c(Cl)c1 |r| InChI=1S/C18H25ClF3N5O/c1-12-11-25(16-15(19)9-13(10-24-16)17(28)23-2)7-8-27(12)14-3-5-26(6-4-14)18(20,21)22/h9-10,12,14H,3-8,11H2,1-2H3,(H,23,28) REMZBQYUEFNDED-UHFFFAOYSA-N 50337261 (S)-5-chloro-N-methyl-6-(3-methyl-4-(1-(trifluoromethyl)piperidin-4-yl)piperazin-1-yl)nicotinamide::CHEMBL1681834 C-X-C chemokine receptor type 3 Homo sapiens 63 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337261 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337261&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53322460 125087363 CHEMBL1681834 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 50624301 CNC(=O)c1cnc(N2CCN([C@@H](C)C2)C2CCN(Cc3ccc(Cl)cc3F)CC2)c(Cl)c1 |r| InChI=1S/C24H30Cl2FN5O/c1-16-14-31(23-21(26)11-18(13-29-23)24(33)28-2)9-10-32(16)20-5-7-30(8-6-20)15-17-3-4-19(25)12-22(17)27/h3-4,11-13,16,20H,5-10,14-15H2,1-2H3,(H,28,33) CQIIQOJWLJNKMY-UHFFFAOYSA-N 50337262 (S)-5-chloro-6-(4-(1-(4-chloro-2-fluorobenzyl)piperidin-4-yl)-3-methylpiperazin-1-yl)-N-methylnicotinamide::CHEMBL1681835 C-X-C chemokine receptor type 3 Homo sapiens 18 ChEMBL 10.1016/j.bmcl.2010.12.114 10.7270/Q2CZ37FJ 21277198 Shao, Y; Anilkumar, GN; Carroll, CD; Dong, G; Hall, JW; Hobbs, DW; Jiang, Y; Jenh, CH; Kim, SH; Kozlowski, JA; McGuinness, BF; Rosenblum, SB; Schulman, I; Shih, NY; Shu, Y; Wong, MK; Yu, W; Zawacki, LG; Zeng, Q 2/21/2011 8/23/2011 Ligand Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50337262 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50337262&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 53326388 125087364 CHEMBL1681835 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5